Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 1 of 1 entries
View as:
Phase: N/A
Priority: Normal
Start: 05/12/25
End: 08/01/28
Due: 08/01/29
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer | NCT06801236 | Acerand Therapeutics (Hong Kong) Limited | user2@example.com | None | 2025-05-12 | 2028-08-01 | 2029-08-01 | - | - | 2025-07-14 |